Last $47.22 USD
Change Today -0.15 / -0.32%
Volume 7.0M
ABT On Other Exchanges
SIX Swiss Ex
Sao Paulo
As of 8:04 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas C. Freyman

Chief Financial Officer and Executive Vice President of Finance, Abbott Laboratories
AgeTotal Calculated CompensationThis person is connected to 17 board members in 5 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Thomas C. Freyman has been the Chief Financial Officer and Executive Vice President of Finance at Abbott Diabetes Care, Inc. since 2001 and February 2004, respectively. Mr. Freyman has been Chief Financial Officer of Abbott Laboratories since 2001 and as its Executive Vice President of Finance since 2004. He serves as the Chief Executive Officer and Chief Financial Officer of Abbott Health Products Inc. He joined Abbott on February 1, 1979, where he served in a number ...

Read Full Background

Corporate Headquarters*

100 Abbott Park Road
Abbott Park, Illinois 60064

United States

Phone: 847-937-6100
Fax: --

Board Members Memberships*

Former Director
Former Director
Director and Member of Audit Committee


University of Illinois-Urbana-Champaign
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$969,748

Stock Options*

Restricted Stock Awards$2,009,050
All Other Compensation$157,121
Exercised Options404,215
Exercised Options Value$6,162,501
Exercisable Options967,200
Unexercisable Options499,900
Total Value of Options$6,162,501
Total Number of Options1,871,315

Total Compensation*

Total Annual Cash Compensation$2,038,869
Total Short Term Compensation$969,748
Other Long Term Compensation$2,166,171
Total Calculated Compensation$5,881,754
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:US $47.22 USD -0.15


Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at